Discover Tenders by Drugs Cancer Oncology Sector

Find the most relevant tenders for Drugs Cancer Oncology. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Drugs Cancer Oncology tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Drugs Cancer Oncology tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Amifampridine Atc N07Xx05 For The Period 01 09 2025 31 08 2027 Plus Extension Option 1X12 Months

Deadline: 05 Jul 2028

Germany

Ref. No.: 18538698

EMD:Ref Document

Bid Value: Ref Document

941 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V For The Active Ingredient Naproxen Esomeprazol Atc M01Ae52 F D Z 01 09 2025 31 08 2027 Plus Extension Option 1X12 Months

Deadline: 05 Jul 2028

Germany

Ref. No.: 18538565

EMD:Ref Document

Bid Value: Ref Document

941 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V For The Active Ingredient Abrocitinib Atc D11Ah08 For The Time 01 09 2025 31 08 2027

Deadline: 05 Jul 2027

Germany

Ref. No.: 18537577

EMD:Ref Document

Bid Value: Ref Document

575 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V To The Active Ingredient Umeclidinum Atc R03Bb07 For The Period 01 09 2025 31 08 2027

Deadline: 05 Jul 2027

Germany

Ref. No.: 18535921

EMD:Ref Document

Bid Value: Ref Document

575 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Tofacitinib Atc L04Af01 For The Period 01 09 2025 31 08 2027 Plus Extension Option 1X12 Months

Deadline: 05 Jul 2028

Germany

Ref. No.: 18535573

EMD:Ref Document

Bid Value: Ref Document

941 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Axitinib Atc L01Ek01 For The Time 01 09 2025 31 08 2027 Plus Extension Option 1X12 Months

Deadline: 05 Jul 2028

Germany

Ref. No.: 18532003

EMD:Ref Document

Bid Value: Ref Document

941 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Glaceprevir And Pibrentasvir Atc J05Ap57 For The Period 01 09 2025 31 08 2027

Deadline: 05 Jul 2027

Germany

Ref. No.: 18530733

EMD:Ref Document

Bid Value: Ref Document

575 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Ruxolitinib Atc D11Ah09 For The Period 01 09 2025 31 08 2027

Deadline: 05 Jul 2027

Germany

Ref. No.: 18529644

EMD:Ref Document

Bid Value: Ref Document

575 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V For The Active Ingredient Abrocitinib Atc D11Ah08 For The Time 01 09 2025 31 08 2027

Deadline: 05 Jul 2027

Germany

Ref. No.: 18528080

EMD:Ref Document

Bid Value: Ref Document

575 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V To The Active Ingredient Umeclidinum Atc R03Bb07 For The Period 01 09 2025 31 08 2027

Deadline: 05 Jul 2027

Germany

Ref. No.: 18527118

EMD:Ref Document

Bid Value: Ref Document

575 Days Left

Open House Pharmaceuticals Advice Treaties Adalimumab Atc L04Ab04

Deadline: 03 Jul 2027

Germany

Ref. No.: 18423829

EMD:Ref Document

Bid Value: Ref Document

573 Days Left

Open House Pharmaceutical Dact Treaties Erythropoietin Alfa Atc B03Xa01

Deadline: 03 Jul 2027

Germany

Ref. No.: 18414494

EMD:Ref Document

Bid Value: Ref Document

573 Days Left

Medicines With The Active Ingredient Tolvaptan Atc G04Bx21 Except Drugs With Uniform Effects

Deadline: 30 Jun 2027

Germany

Ref. No.: 18408647

EMD:Ref Document

Bid Value: Ref Document

570 Days Left

Medicines With The Active Ingredient Tolvaptan Atc G04Bx21 Except Drugs With Uniform Effects

Deadline: 30 Jun 2027

Germany

Ref. No.: 18398115

EMD:Ref Document

Bid Value: Ref Document

570 Days Left

Lextox Drug And Alcohol Testing

Deadline: 31 Mar 2026

United Kingdom

Ref. No.: 18365432

EMD:Ref Document

Bid Value: Ref Document

114 Days Left

Showing 32236 to 32250 of 32927 results

‹
1
2
...
2147
2148
2149
2150
2151
2152
2153
...
2195
2196
›

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

FREE Trial plan for all new users!